{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T07:01:32Z","timestamp":1790146892390,"version":"4.0.1"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>\n                    Nitazoxanide (NTZ), an FDA-approved anti-parasitic drug, has shown anti-inflammatory effects in rheumatoid arthritis (RA) fibroblast-like synoviocytes, yet its impact on immune cell function and its potential synergy with methotrexate (MTX) remains unclear. In this study, using a murine collagen-induced arthritis (CIA) model, we demonstrated that NTZ synergizes with MTX to delay arthritis onset and ameliorate joint pathology, accompanied by reduced inflammatory cell infiltration, synovial pannus formation, and bone destruction. Moreover, NTZ significantly suppressed inflammatory cytokine production in both murine splenocytes and human peripheral blood mononuclear cells from healthy donors and RA patients.\n                    <jats:italic>In vivo<\/jats:italic>\n                    findings from the CIA model further demonstrated that NTZ suppressed synovial IL-6 and pSTAT3 expression, as well as Th17 cell differentiation. And these effects collectively contributed to the improvement in arthritis score. Mechanistically, NTZ markedly inhibited the STAT3 signaling pathway in immune cells upon IL-6 or anti-CD3 stimulation. Additionally, it potently suppressed osteoclast differentiation of monocytes derived from RA patients. Taken together, this study provides a proof-of-concept for NTZ\u2019s immunomodulatory activity in RA, yet the data remain insufficient for therapeutic claims and only lay the groundwork for further studies.\n                  <\/jats:p>","DOI":"10.3389\/fphar.2026.1877306","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:17:50Z","timestamp":1790144270000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Nitazoxanide alleviates collagen-induced arthritis by inhibiting STAT3-dependent Th17 cell differentiation and inflammatory cytokines production"],"prefix":"10.3389","volume":"17","author":[{"given":"Changhong","family":"Li","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Immunology, Peking University Third Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Peking University Third Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijun","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Peking University Third Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Niu","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Peking University Health Science Center","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijie","family":"Leng","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, Peking University Third Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxia","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Peking University Third Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"100991","DOI":"10.1016\/j.jlr.2026.100991","article-title":"JNK1 mediates serine phosphorylation of STAT3 in response to fatty acids released by lipolysis","volume":"67","author":"Aksu","year":"2026","journal-title":"J. Lipid Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41584-018-0109-2","article-title":"Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis","volume":"15","author":"Chen","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"102019","DOI":"10.1016\/j.berh.2024.102019","article-title":"Global RA treatment recommendations: an update from the various international societies","volume":"39","author":"Cubberley","year":"2025","journal-title":"Best. Pract. Res. Clin. Rheumatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"4813","DOI":"10.1038\/s41467-024-48807-y","article-title":"High-throughput screening unveils nitazoxanide as a potent PRRSV inhibitor by targeting NMRAL1","volume":"15","author":"Cui","year":"2024","journal-title":"Nat. Commun."},{"key":"B5","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1002\/art.42767","article-title":"Poly-refractory rheumatoid arthritis: an uncommon subset of difficult to treat disease with distinct inflammatory and noninflammatory phenotypes","volume":"76","author":"David","year":"2024","journal-title":"Arthritis Rheumatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1093\/rheumatology\/keac645","article-title":"Machine learning identifies a profile of inadequate responder to methotrexate in rheumatoid arthritis","volume":"62","author":"Duquesne","year":"2023","journal-title":"Rheumatol. Oxf."},{"key":"B7","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.actatropica.2019.04.013","article-title":"Evaluation of nitazoxanide as a novel drug for the treatment of acute and chronic toxoplasmosis","volume":"195","author":"El-Kowrany","year":"2019","journal-title":"Acta Trop."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1158\/1535-7163.MCT-12-1243","article-title":"A c-Myc activation sensor-based high-throughput drug screening identifies an antineoplastic effect of nitazoxanide","volume":"12","author":"Fan-Minogue","year":"2013","journal-title":"Mol. Cancer Ther."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1002\/art.41752","article-title":"2021 American College of Rheumatology Guideline for the treatment of rheumatoid arthritis","volume":"73","author":"Fraenkel","year":"2021","journal-title":"Arthritis Rheumatol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.3390\/ijms18071538","article-title":"Combination therapy of PEG-HM-3 and methotrexate retards adjuvant-induced arthritis","volume":"18","author":"Hao","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2040622320916026","DOI":"10.1177\/2040622320916026","article-title":"Are gene polymorphisms related to adverse events of methotrexate in patients with rheumatoid arthritis? A retrospective cohort study based on an updated meta-analysis","volume":"11","author":"Huang","year":"2020","journal-title":"Ther. Adv. Chronic Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1007\/s00774-015-0702-2","article-title":"Methotrexate inhibits osteoclastogenesis by decreasing RANKL-Induced calcium influx into osteoclast progenitors","volume":"34","author":"Kanagawa","year":"2016","journal-title":"J. Bone Min. Metab."},{"key":"B13","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.1007\/s10787-023-01263-4","article-title":"The African Kelleni's roadmap using nitazoxanide and broad-spectrum antimicrobials to abort returning to COVID-19 square one","volume":"31","author":"Kelleni","year":"2023","journal-title":"Inflammopharmacology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1021\/acsptsci.4c00067","article-title":"Unveiling novel drug targets and emerging therapies for rheumatoid arthritis: a comprehensive review","volume":"7","author":"Khokhar","year":"2024","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1080\/08830185.2025.2515836","article-title":"Immunological insights into role of Th9 and Treg cell homeostasis and cytokines dynamics in the progression of diabetic nephropathy","volume":"44","author":"Khokhar","year":"2025","journal-title":"Int. Rev. Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"512","DOI":"10.3390\/antiox14050512","article-title":"Nitazoxanide modulates mitochondrial function and inflammatory metabolism in chondrocytes from patients with osteoarthritis via AMPK\/mTORC1 signaling","volume":"14","author":"Kim","year":"2025","journal-title":"Antioxidants (Basel)"},{"key":"B17","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nm.3432","article-title":"Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis","volume":"20","author":"Komatsu","year":"2014","journal-title":"Nat. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e1002691","DOI":"10.1371\/journal.ppat.1002691","article-title":"Nitazoxanide stimulates autophagy and inhibits mTORC1 signaling and intracellular proliferation of Mycobacterium tuberculosis","volume":"8","author":"Lam","year":"2012","journal-title":"PLoS Pathog."},{"key":"B19","doi-asserted-by":"publisher","first-page":"R31","DOI":"10.1186\/ar4179","article-title":"IL-17-mediated Bcl-2 expression regulates survival of fibroblast-like synoviocytes in rheumatoid arthritis through STAT3 activation","volume":"15","author":"Lee","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"B20","doi-asserted-by":"publisher","first-page":"781640","DOI":"10.3389\/fphar.2021.781640","article-title":"Nitazoxanide, an antiprotozoal drug, reduces bone loss in ovariectomized mice by inhibition of RANKL-induced osteoclastogenesis","volume":"12","author":"Li","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"116195","DOI":"10.1016\/j.biopha.2024.116195","article-title":"Nitazoxanide reduces inflammation and bone erosion in mice with collagen-induced arthritis via inhibiting the JAK2\/STAT3 and NF-\u03baB pathways in fibroblast-like synoviocytes","volume":"171","author":"Li","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"B22","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1021\/acsmedchemlett.0c00544","article-title":"Structure-activity study of nitazoxanide derivatives as novel STAT3 pathway inhibitors","volume":"12","author":"L\u00fc","year":"2021","journal-title":"ACS Med. Chem. Lett."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1016\/S0140-6736(17)31472-1","article-title":"Pathogenetic insights from the treatment of rheumatoid arthritis","volume":"389","author":"McInnes","year":"2017","journal-title":"Lancet"},{"key":"B24","doi-asserted-by":"publisher","first-page":"109798","DOI":"10.1016\/j.isci.2024.109798","article-title":"GSK2334470 attenuates high salt-exacerbated rheumatoid arthritis progression by restoring Th17\/Treg homeostasis","volume":"27","author":"Mo","year":"2024","journal-title":"iScience"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1093\/mr\/roae049","article-title":"Systematic review and meta-analysis for the 2024 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis","volume":"34","author":"Nakayama","year":"2024","journal-title":"Mod. Rheumatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"dev199477","DOI":"10.1242\/dev.199477","article-title":"Y705 and S727 are required for the mitochondrial import and transcriptional activities of STAT3, and for regulation of stem cell proliferation","volume":"148","author":"Peron","year":"2021","journal-title":"Development"},{"key":"B27","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nchembio.2510","article-title":"Small molecule promotes \u03b2-catenin citrullination and inhibits wnt signaling in cancer","volume":"14","author":"Qu","year":"2018","journal-title":"Nat. Chem. Biol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet"},{"key":"B29","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/ard-2022-223356","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update","volume":"82","author":"Smolen","year":"2023","journal-title":"Ann. Rheum. Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.ard.2026.01.023","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biologic disease-modifying antirheumatic drugs: 2025 update","volume":"85","author":"Smolen","year":"2026","journal-title":"Ann. Rheum. Dis."},{"key":"B31","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1126\/science.1199214","article-title":"The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice","volume":"332","author":"Tang","year":"2011","journal-title":"Science"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e004886","DOI":"10.1136\/rmdopen-2024-004886","article-title":"Methotrexate inhibits glucocorticoids-induced osteoclastogenesis via activating IFN-\u03b3R\/STAT1 pathway in the treatment of rheumatoid arthritis","volume":"10","author":"Teng","year":"2024","journal-title":"RMD Open"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e70130","DOI":"10.1111\/1756-185x.70130","article-title":"The safety and efficacy of JAK inhibitors: have we found the right pathway?","volume":"28","author":"Wang","year":"","journal-title":"Int. J. Rheum. Dis."},{"key":"B34","doi-asserted-by":"publisher","first-page":"123302","DOI":"10.1016\/j.lfs.2024.123302","article-title":"Nitazoxanide alleviates experimental pulmonary fibrosis by inhibiting the development of cellular senescence","volume":"361","author":"Wang","year":"","journal-title":"Life Sci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1586\/14787210.2.1.43","article-title":"Nitazoxanide: a new broad spectrum antiparasitic agent","volume":"2","author":"White","year":"2004","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"B36","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/s41586-023-05801-6","article-title":"The dietary sweetener sucralose is a negative modulator of T cell-mediated responses","volume":"615","author":"Zani","year":"2023","journal-title":"Nature"},{"key":"B37","doi-asserted-by":"publisher","first-page":"113074","DOI":"10.1016\/j.biopha.2022.113074","article-title":"Application and pharmacological mechanism of methotrexate in rheumatoid arthritis","volume":"150","author":"Zhao","year":"2022","journal-title":"Biomed. Pharmacother."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1877306\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:17:51Z","timestamp":1790144271000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1877306\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":37,"alternative-id":["10.3389\/fphar.2026.1877306"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1877306","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]},"article-number":"1877306"}}